GB9024862D0 - Biogradable injectable microspheres,a process for their preparation and injectable suspensions containing the same - Google Patents

Biogradable injectable microspheres,a process for their preparation and injectable suspensions containing the same

Info

Publication number
GB9024862D0
GB9024862D0 GB909024862A GB9024862A GB9024862D0 GB 9024862 D0 GB9024862 D0 GB 9024862D0 GB 909024862 A GB909024862 A GB 909024862A GB 9024862 A GB9024862 A GB 9024862A GB 9024862 D0 GB9024862 D0 GB 9024862D0
Authority
GB
United Kingdom
Prior art keywords
injectable
biogradable
preparation
same
suspensions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB909024862A
Other versions
GB2239798B (en
GB2239798A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB9024862D0 publication Critical patent/GB9024862D0/en
Publication of GB2239798A publication Critical patent/GB2239798A/en
Application granted granted Critical
Publication of GB2239798B publication Critical patent/GB2239798B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB9024862A 1989-11-15 1990-11-15 Biodegradable injectable microsphere steroid formulations. Expired - Fee Related GB2239798B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR898914976A FR2654337B1 (en) 1989-11-15 1989-11-15 NOVEL BIODEGRADABLE INJECTABLE MICROSPHERES PREPARATION METHOD AND INJECTABLE SUSPENSIONS CONTAINING THEM.

Publications (3)

Publication Number Publication Date
GB9024862D0 true GB9024862D0 (en) 1991-01-02
GB2239798A GB2239798A (en) 1991-07-17
GB2239798B GB2239798B (en) 1993-10-27

Family

ID=9387417

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9024862A Expired - Fee Related GB2239798B (en) 1989-11-15 1990-11-15 Biodegradable injectable microsphere steroid formulations.

Country Status (13)

Country Link
JP (1) JPH03294229A (en)
AT (1) AT400298B (en)
BE (1) BE1005511A4 (en)
CA (1) CA2029940A1 (en)
CH (1) CH681691A5 (en)
DE (1) DE4036425A1 (en)
DK (1) DK270990A (en)
FR (1) FR2654337B1 (en)
GB (1) GB2239798B (en)
IT (1) IT1242010B (en)
LU (1) LU87836A1 (en)
NL (1) NL9002492A (en)
SE (1) SE9003570L (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222501B1 (en) * 1991-06-28 2003-07-28 Endorecherche Inc. Controlled release pharmaceutical composition containing mpa or mga and process for its preparation
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
CZ285522B6 (en) * 1993-06-24 1999-08-11 Eli Lilly And Company Medicament for reducing concentration of glucose in blood
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
EP2210585A1 (en) 2009-01-16 2010-07-28 Exelgyn SPRM pharmaceutical compositions methods of treatment using them

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (en) * 1982-06-11 1985-07-19 Roussel Uclaf NOVEL 19-NOR STEROIDS SUBSTITUTED IN 11B AND POSSIBLY IN 2, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT
US4530840A (en) * 1982-07-29 1985-07-23 The Stolle Research And Development Corporation Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
FR2537980B1 (en) * 1982-12-17 1986-12-19 Sandoz Sa OLIGOMERIC HYDROXYCARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE
ES8502612A1 (en) * 1983-06-15 1985-02-01 Schering Ag 13-Alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them.
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
JPS60100516A (en) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd Preparation of sustained release microcapsule
DE3347126A1 (en) * 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen 11SS-ARYL-ESTRADIENE, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM
FR2566779B2 (en) * 1984-06-29 1987-03-06 Roussel Uclaf NOVEL 11B SUBSTITUTED STEROID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
CA1256638A (en) * 1984-07-06 1989-06-27 Motoaki Tanaka Polymer and its production
FR2573657B1 (en) * 1984-11-29 1989-05-12 Roussel Uclaf PRODUCT COMPRISING AN ANTIPROGESTOMIMETIC SUBSTANCE AND A UTEROTONIC SUBSTANCE
DE3533175A1 (en) * 1985-09-13 1987-03-19 Schering Ag ANTIGESTAGES TO SHIFT ENDOMETRIAL MATURATION
FR2596395B1 (en) * 1986-03-26 1989-05-26 Roussel Uclaf NOVEL STEROIDS COMPRISING A SPIRANIC CYCLE IN POSITION 17, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3633244A1 (en) * 1986-09-26 1988-03-31 Schering Ag ANTIGESTAGE FOR INHIBITING UTERINE PROSTAGLAND INSYNTHESIS
EP0310542B1 (en) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagenic and antioestrogenic compounds for the treatment of hormone-dependent tumours
DE3733478A1 (en) * 1987-10-01 1989-04-13 Schering Ag ANTIGESTAGEN AND ANTIOOTROGENIC COMPOUNDS FOR THE INTRODUCTION OF BIRTH AND PREGNANCY, AND THE TREATMENT OF GYNAECOLOGICAL DISORDER AND HORMONE-RELATED TUMORS
DE3744054A1 (en) * 1987-12-21 1989-06-29 Schering Ag USE OF ANTIGESTAGES FOR THE PRODUCTION OF MEDICINAL PRODUCTS
BE1004905A4 (en) * 1987-12-30 1993-02-23 Roussel Uclaf NOVEL 17BETA-OH 19-NOR DERIVATIVES SUBSTITUTED IN 17ALPHA, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JP2670680B2 (en) * 1988-02-24 1997-10-29 株式会社ビーエムジー Polylactic acid microspheres containing physiologically active substance and method for producing the same

Also Published As

Publication number Publication date
IT1242010B (en) 1994-02-02
BE1005511A4 (en) 1993-08-31
NL9002492A (en) 1991-06-03
CA2029940A1 (en) 1991-05-16
AT400298B (en) 1995-11-27
DK270990D0 (en) 1990-11-13
ATA231390A (en) 1995-04-15
DE4036425A1 (en) 1991-05-16
IT9048470A1 (en) 1992-05-13
SE9003570D0 (en) 1990-11-09
CH681691A5 (en) 1993-05-14
JPH03294229A (en) 1991-12-25
IT9048470A0 (en) 1990-11-13
FR2654337B1 (en) 1994-08-05
GB2239798B (en) 1993-10-27
LU87836A1 (en) 1991-05-07
DK270990A (en) 1991-05-16
SE9003570L (en) 1991-05-16
FR2654337A1 (en) 1991-05-17
GB2239798A (en) 1991-07-17

Similar Documents

Publication Publication Date Title
GB2237089B (en) Locking mechanisms
ZA909681B (en) Structural member
GB2237862B (en) Absorbers
EP0427905A3 (en) Grid-inserted quantum structure
GB8905085D0 (en) Filaments
GB9024862D0 (en) Biogradable injectable microspheres,a process for their preparation and injectable suspensions containing the same
GB8924941D0 (en) Suspension arrangement
EP0425988A3 (en) Sorter
EP0416363A3 (en) Modified polyarylenesulfides
IL96563A0 (en) Thread
GB9021092D0 (en) Locking mechanisms
GR3017119T3 (en) 1-E3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl]-3-phenyl-1-propanon and process for its preparation.
GB9013131D0 (en) Particle sorting
GB8924339D0 (en) Can bin
IL91671A0 (en) Opaliform porcellanite and process for the preparation thereof
EP0425987A3 (en) Sorter
GB8926183D0 (en) Multiple quantum well structures
GB8911795D0 (en) Filaments
ZA904180B (en) Bin
AU108376S (en) Bin
AU108198S (en) Bin
AU108375S (en) Bin
CS8905673A2 (en) Suspension
HRP920783A2 (en) Injectable solution and a process for preparing the same
GB8926694D0 (en) Sorters

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19981115